mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.6 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.6 |